ORMDL3 and colitis: In order to access the role of ORMDL3 in the colitis formation, we organized the animal into three experimental groups namely, control, DSS treatment with nontargeted shRNA (DSS-sh-NT), and DSS treatment with ORMDL3 shRNA (DSS-sh-ORMDL3).